Evidence map›Paper›PMID 31477057›Full record

ArticleBMC nephrology2019

Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.

Friederike Petzold, Anette Bachmann, Carsten Bergmann, Udo Helmchen, Jan Halbritter

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC nephrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Renal transplantation in Alport syndrome.Kidney research and clinical practice · 2025
    Article
  2. Review
  3. Article
  4. Article
  5. Guidelines for Genetic Testing and Management of Alport Syndrome.Clinical journal of the American Society of Nephrology : CJASN · 2022
    Article
  6. Novel Therapies for Alport Syndrome.Frontiers in medicine · 2022
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Friederike PetzoldDivision of Nephrology, Department of Internal Medicine, University Hospital Leipzig, Liebigstr, 2004103, Leipzig, Germany.
Anette BachmannDivision of Nephrology, Department of Internal Medicine, University Hospital Leipzig, Liebigstr, 2004103, Leipzig, Germany.
Carsten BergmannBioscientia, Institute of Human Genetics, Ingelheim, Germany.
Udo HelmchenCenter for Diagnostics, Institute of Pathology, University Hospital Eppendorf Hamburg, Hamburg, Germany.
Jan HalbritterDivision of Nephrology, Department of Internal Medicine, University Hospital Leipzig, Liebigstr, 2004103, Leipzig, Germany. jan.halbritter@medizin.uni-leipzig.de.
University Hospital Leipzig · DEUniversität Hamburg · DEUniversity Medical Center Freiburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKidney transplantation is the treatment of choice in end-stage renal disease due to Alport syndrome (AS). However, the chances of finding an adequate living-related donor in AS are much worse compared to non-heritable conditions. Successful cases of related living-donor transplantation mostly refer to X-linked AS but are rarely reported in genetically confirmed autosomal AS. CASE PRESENTATION: We describe the outcome of an exceptional AB0-incompatible kidney donation from father to son in a family with altered COL4A3. While decision-making was based on extensive clinical donor evaluation prior to transplantation, we analyzed the underlying genetic background in retrospect and associated these findings with the phenotype in all available family members. While biallelic COL4A3 variants caused autosomal recessive AS (ARAS) in the son (recipient), heterozygous family members, including the father (donor), showed minimal renal involvement and high-frequency sensorineural hearing impairment later in life indicating mild autosomal dominant Alport syndrome (ADAS). The recipient's successful participation in the European and World Transplant Games is a testament to the positive outcome of transplantation.

conclusionsIn summary, living-related donor transplantation may be successful in autosomal AS, provided that thorough clinical and genetic evaluation of potential donors is performed. However, unrelated kidney transplantation should be given priority upon unpredictable genetic risk. Individual genetic variant interpretation is an important component of personalized donor assessment and will help to better predict genetic risk in the future.

Indexed as

Living DonorsAdultAutoantigensCollagen Type IVGenetic TestingHumansKidney TransplantationMaleNephritis, HereditaryPedigreeRetrospective StudiesAutoantigensCollagen Type IVtype IV collagen alpha3 chainADASAlport syndromeARASCOL4A3ESRDLRKTxTBMNTransplantation

Identifiers

PMID31477057
PMCPMC6721183
OpenAlexW2972126565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.